tiprankstipranks
Trending News
More News >
Avanos Medical (AVNS)
NYSE:AVNS

Avanos Medical (AVNS) Price & Analysis

Compare
174 Followers

AVNS Stock Chart & Stats

$11.84
-$0.16(-1.03%)
At close: 4:00 PM EST
$11.84
-$0.16(-1.03%)

Bulls Say, Bears Say

Bulls Say
Business DevelopmentsAVNS recorded some positive developments during the quarter, which include completing the divestiture of its respiratory health business, exceeding internal expectations on its Trident U.S. market launch, as well as improving its capital position.
Financial PerformanceAvanos Medical posted a moderate quarterly beat on both the top and bottom lines, with a strong quarter from its Digestive Health business.
Bears Say
Guidance And Market ConditionsManagement's initial full-year 2025 guidance was light of Street expectations, calling for flat to slight declines in both revenue and earnings, reflecting a challenging market environment for some of its product categories, currency headwinds, and other macro factors.
Pricing PressuresThe hyaluronic acid injection business continues to be a sore spot with ongoing pricing pressures highlighted as a key factor underpinning the company’s below-Consensus initial 2025 guidance.

Avanos Medical News

AVNS FAQ

What was Avanos Medical’s price range in the past 12 months?
Avanos Medical lowest stock price was $9.30 and its highest was $15.68 in the past 12 months.
    What is Avanos Medical’s market cap?
    Avanos Medical’s market cap is $650.58M.
      When is Avanos Medical’s upcoming earnings report date?
      Avanos Medical’s upcoming earnings report date is May 06, 2026 which is in 62 days.
        How were Avanos Medical’s earnings last quarter?
        Avanos Medical released its earnings results on Feb 24, 2026. The company reported $0.29 earnings per share for the quarter, beating the consensus estimate of $0.25 by $0.04.
          Is Avanos Medical overvalued?
          According to Wall Street analysts Avanos Medical’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Avanos Medical pay dividends?
            Avanos Medical does not currently pay dividends.
            What is Avanos Medical’s EPS estimate?
            Avanos Medical’s EPS estimate is 0.14.
              How many shares outstanding does Avanos Medical have?
              Avanos Medical has 46,503,456 shares outstanding.
                What happened to Avanos Medical’s price movement after its last earnings report?
                Avanos Medical reported an EPS of $0.29 in its last earnings report, beating expectations of $0.25. Following the earnings report the stock price went down -10.44%.
                  Which hedge fund is a major shareholder of Avanos Medical?
                  Currently, no hedge funds are holding shares in AVNS
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    Avanos Medical

                    Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

                    Avanos Medical (AVNS) Earnings & Revenues

                    AVNS Company Deck

                    AVNS Earnings Call

                    Q4 2026
                    0:00 / 0:00
                    Earnings Call Sentiment|Positive
                    The call conveyed solid operational execution and portfolio reshaping that produced revenue outperformance, margin expansion in key segments, strong cash generation, and successful M&A integration (Nexus). However, a material near-term headwind from tariffs (approximately $30M expected in 2026) and lingering softness in certain product lines (surgical pain, GAME READY, HA/IV exits) will weigh on margins in the near term. Management presented a credible mitigation path (China exit, production shift to Mexico/SE Asia, cost containment, pricing) and provided constructive 2026 guidance, indicating confidence in returning to margin improvement in H2 2026 and beyond.View all AVNS earnings summaries
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Orthofix Medical
                    Varex Imaging
                    OrthoPediatrics
                    Bioventus

                    Ownership Overview

                    2.11%25.75%20.15%24.68%
                    20.15% Other Institutional Investors
                    24.68% Public Companies and
                    Individual Investors
                    Popular Stocks